What is the Efficacy and Safety of the HPV Vaccine?

October 29, 2014 :: Nubia Muñoz MD MPH
Moderated by Jillian King

Millions of people around the world are currently infected with the genital human papillomavirus (HPV) and as many as half of these infections are among adolescents and young adults, ages 15 through 24 years of age. HPV is so common that most sexually active adults become infected at some point in their lives, sometime leading to cervical and other forms of cancers.

HPV vaccines are now available and the speaker will discuss the reasons why she believe vaccinations are important and as well, outline the efficacy and safety of such vaccines.

Speaker: Nubia Muñoz MD MPH

Nubia Muñoz MD MPH is a former Unit chief at the International Agency for Research on Cancer in Lyon, an Emeritus Scientist of the National Cancer Institute of Colombia, and a member of the Society of Scholars of Johns Hopkins University in Baltimore, USA.

Dr. Muñoz earned her Medical Degree and Board of Pathologist at the University of Valle in Cali, Colombia. She served a Fellowship in pathology and virology at the National Cancer Institute in Bethesda, Maryland, and earned a Master’s Degree in Public Health and Cancer Epidemiology from The Johns Hopkins University in Baltimore, Maryland.

After completing her training, she had a 30 years career at the International Agency for Research on Cancer (IARC) in Lyon, France. Through successive promotions she achieved the rank of Chief at the Unit of Field and Intervention Studies, a position she held until 2002. In 2009, Dr. Muñoz was the first recipient of the prestigious Gairdner Global Health award.

Moderator: Jillian King

Date: Wednesday, October 29, 2014
Time: 7:00 – 9:00 pm
Location: Dr. Foster James Penny Building, 324 - 5 Street South (downtown)

Free event, everyone welcome

Share URL: http://sacpa.ca/52C36